← FDA Drug Approvals (Drugs@FDA)
HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2017-05-15
Drug application
- FDA Application #
ANDA206660- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
- Generic name
- Chlorpheniramine Maleate
- Active ingredients
- CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SCIEGEN PHARMS
- First approval
- 2017-05-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown